SolventumSOLV财报
NYSE · 医疗保健 · 医疗保健技术
Solventum是一家总部位于美国的医疗健康企业，于2024年4月1日正式从全球知名多元化工业集团3M分拆后独立运营，继承了原3M旗下医疗板块的技术积累与业务资源，面向全球市场提供专业医疗相关产品及服务。
主要股东
| 股东 | 持股比例 | 股数 | 变动 | 截至 |
|---|---|---|---|---|
| The Vanguard Group | 9.37% | 16.2M | 无变化 | 2024-11-12 |
| BlackRock, Inc. | 6.10% | 10.6M | 无变化 | 2024-11-08 |
内部人交易
Net 90d: +$100.3K · buys $100.3K / sells $0时间范围:
类型:
身份:
| 内部人 | 身份 | 类型 | ||||
|---|---|---|---|---|---|---|
| 2026-03-27 | EISENBERG GLENN A | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | Harris Bernard A Jr | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | Wilcox Mary T | Chief Accounting Officer | Option exercise | 5.2K | $0.00 | $0 |
| 2026-03-27 | Edwards Shirley Ann | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | DeVore Susan D. | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | COX CARRIE SMITH | Director | Option exercise | 6.3K | $0.00 | $0 |
| 2026-03-27 | Wilson Darryl L. | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | WEILAND JOHN H | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | MAY KAREN J | Director | Option exercise | 2.0K | $0.00 | $0 |
| 2026-03-27 | ALBAN CARLOS | Director | Option exercise | 2.0K | $0.00 | $0 |
1–10 of 20
第 1 页 / 共 2 页